Cargando…
GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells
GPR21 is a constitutively active, orphan, G-protein-coupled receptor, with in vivo studies suggesting its involvement in the modulation of insulin sensitivity. However, its precise contribution is not fully understood. As the liver is both a major target of insulin signalling and critically involved...
Autores principales: | Kinsella, Gemma K., Cannito, Stefania, Bordano, Valentina, Stephens, John C., Rosa, Arianna C., Miglio, Gianluca, Guaschino, Valeria, Iannaccone, Valeria, Findlay, John B. C., Benetti, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509304/ https://www.ncbi.nlm.nih.gov/pubmed/34639123 http://dx.doi.org/10.3390/ijms221910784 |
Ejemplares similares
-
Regulating the effects of GPR21, a novel target for type 2 diabetes
por: Leonard, Siobhán, et al.
Publicado: (2016) -
Sedentariness and Urinary Metabolite Profile in Type 2 Diabetic Patients, a Cross-Sectional Study
por: Benetti, Elisa, et al.
Publicado: (2020) -
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro
por: Mochalski, Paweł, et al.
Publicado: (2013) -
Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation
por: Zhang, Yucheng, et al.
Publicado: (2012) -
MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells
por: MAO, BIJING, et al.
Publicado: (2015)